Recent Finacing
Recent Raise
Millendo Therapeutics develops endocrine therapeutics, advancing an NK3 receptor antagonist for PCOS and an ACAT1 inhibitor for adrenocortical carcinoma and other adrenal disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors